Very strange, J&J mucked around with the trial so it's no longer statistically significant. AND, they mucked with it when the drug doesn't show any survival advantage until after 18 months (when the stuff is only given for 14 months) And, this is the wonder drug that's killing Provenge? the prostate cancer drug story just gets stranger and stranger.... http://seekingalpha.com/article/634551-johnson-johnson-s-zytiga-data-argue-for-sequencing-dendreon-s-provenge-first
" ... certain prostate cancer patients ..." so JNJ are looking at data of sub-population and expecting to get approval when the trial was stopped before showing stat-sig survival? gg
